Cannabinoid receptor 1 (CB1) complex with delta (9)-tetrahydrocannabinol (THC) (spheres model) that agonizes the anandamide (molecule upper-left) bounding. CB1 is a seven trasmembrane receptor and the principal target of THC, a psychoactive chemical from Cannabis sativa with a wide range of therapeutic applications and a long history of recreational use. CB1 is activated by endocannabinoids like anandamide afatty acid neurotransmitter (N-arachidonoylethanolamine or AEA) and is a promising therapeutic target for pain management, inflammation, obesity, and substance abuse disorders.
Cannabinoid receptor 1 (CB1) complex with delta (9)-tetrahydrocannabinol (THC) (spheres model) that agonizes the anandamide (molecule upper-left) bounding. CB1 is a seven trasmembrane receptor and the principal target of THC, a psychoactive chemical from Cannabis sativa with a wide range of therapeutic applications and a long history of recreational use. CB1 is activated by endocannabinoids like anandamide afatty acid neurotransmitter (N-arachidonoylethanolamine or AEA) and is a promising therapeutic target for pain management, inflammation, obesity, and substance abuse disorders.
